๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer
NCT06725940Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine
Observational
50
Shanghai
2024-11-01
Recruiting
Public Perceptions Toward Robotic Surgery, Telesurgery and Telemedicine
NCT06803719Robotic Surgery, Telemedicine
Shanghai 6th People's Hospital
Observational
1,000
Shanghai
2024-11-01
Not yet open
Quantitative Ultrasound Assessment of Abdominal Cavity Space
NCT06634732Sepsis, MODS, Shock
Ruijin Hospital
Observational
125
Shanghai
2024-11-01
Recruiting
Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer
NCT07562711ctDNA, Chemotherapy, Colorectal Cancer
Fudan University
Phase 2
340
Shanghai
2024-11-01
Not yet open
Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer
NCT06593548CRC, MSS, Metastatic Cancer
Fudan University
Phase 2
36
Shanghai
2024-11-01
Recruiting
Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions
NCT06705036Pituitary Tumor
Shanghai Zhongshan Hospital
Observational
20
Shanghai
2024-11-01
Recruiting
Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer
NCT07562503ctDNA, Colorectal Cancer, Chemotherapy
Fudan University
Phase 2
340
Shanghai
2024-11-01
Active, closed
A Pospective, Single-arm, Multicenter Clinical Trial Evaluating Preoperative Neoadjuvant mFOLFOX6 Chemotherapy in Combination With PD1 Monoclonal Antibody in MSS/pMMR Locally Advanced Rectal Cancer
NCT06688786Locally Advanced Rectal Cancer (LARC)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2024-11-01
Recruiting
Postoperative Pain of Robotic, Endoscopic and Open Lateral Neck Dissection
NCT06803732Pain, Postoperative, Thyroid Diseases, Surgery
Shanghai 6th People's Hospital
Observational
600
Shanghai
2024-11-01
Not yet open
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL
NCT06641024Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd
Phase 1
24
Shanghai
2024-11-01
Recruiting
A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)
NCT06709417Esophageal Squamous Cell Carcinoma (ESCC)
Shanghai Chest Hospital
Phase 2
52
Shanghai
2024-11-01
Not yet open
Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC
NCT06639971Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital
Observational
500
Shanghai
2024-11-01
Not yet open
Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL Infarction
NCT06671067Acute Myocardial Infarction, Acute Decompensated Heart Failure (ADHF)
Shanghai 10th People's Hospital
Not applicable
2,000
Kaifeng, Zhengzhou, Shanghai
2024-11-01
By invitation
Study of Time-restricted Eating (TRE) to Clinical Pregnancy Rate in PCOS Women With Glucose Metabolism Disorder Via IVF/ICSI
NCT06666933PCOS, Glucose Metabolism Disorder, IVF Outcome
RenJi Hospital
Not applicable
254
Shanghai
2024-11-01
Recruiting
Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
NCT06994221Acute Myocardial Infarction, Ventricular Aneurysm Following Acute Myocardial Infarction, Myocardial Fibrosis
RenJi Hospital
Observational
20
Shanghai
2024-11-01
Recruiting
Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer
NCT07562659ctDNA, Colorectal Cancer (CRC), Adjuvant Chemotherapy
Fudan University
Phase 2
80
Shanghai
2024-11-01
Not yet open
Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06704542ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Diabetes Mellitus, Impaired Fasting Glucose
Ruijin Hospital
Observational
1,000
Zhengzhou, Wuhan, Shanghai, Hangzhou, Tianjin
2024-11
Not yet open
A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia
NCT06672263Chronic Myelogenous Leukemia
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
120
Beijing, Nanning, Zhengzhou, Shanghai, Hangzhou
2024-11
Recruiting
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNฮฑ in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
NCT06650852Chronic Hepatitis B Virus (HBV) Infection
Brii Biosciences Limited
Phase 2
250
Beijing, Guangzhou, Shenzhen, Shanghai, Chengdu, Hangzhou
2024-10-31
Active, closed
Predictive Analysis of Diabetic Foot Ulcer
NCT06768554Diabetic Foot Ulcer (DFU), Diabetic Foot Disease, Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
2,000
Shanghai
2024-10-31
Recruiting
A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib
NCT06699472Ewing Sarcoma, Myelosuppression
Fudan University
Phase 2
22
Shanghai
2024-10-31
Not yet open
PK and PD of YG1699 in CKD Patients With Diabetes
NCT06648876Diabetes, Renal Insufficiency, Chronic, Hemodialysis
RenJi Hospital
Phase 1
20
Shanghai
2024-10-31
Not yet open
Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia
NCT06652685Acute Myeloid Leukemia (AML)
Ruijin Hospital
Phase 2
218
Shanghai
2024-10-30
Recruiting
A Study of the ILB-3101 in Patients with Advanced Solid Tumors
NCT06426680Advanced Solid Tumor
Innolake Biopharm
Phase 1
240
Shanghai
2024-10-30
Recruiting
Multicenter iTBS Neuromodulation for PTSD Treatment
NCT06434766Posttraumatic Stress Disorder
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
140
Shanghai, Hangzhou, Ningbo
2024-10-30
Recruiting
A Study of HS-20124 in Patients with Advanced Solid Tumors
NCT06763159Solid Cancer
Hansoh BioMedical R&D Company
Phase 1
450
Shanghai
2024-10-30
Recruiting
A Prospective Multicenter Clinical Study๏ผš IntracOronary neaR-Infrared Spectroscopy and OptIcal Coherence Tomography for Evaluating Coronary vulNerable Plaque in Patients With diabeTes
NCT06649305Coronary Heart Disease (CHD), Diabetes (DM)
Shanghai Zhongshan Hospital
Observational
1,516
Shanghai
2024-10-30
Active, closed
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
NCT06644768Non-small Cell Lung Cancer, Lung Cancer
Daiichi Sankyo
Phase 1/2
137
Changchun, Hangzhou, Harbin, Jiamusi, Shanghai, Tiyuan, Zhengzhou
2024-10-30
Recruiting
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
NCT06686108T-cell Acute Lymphoblastic Leukemia, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Relapse
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
59
Shanghai
2024-10-30
Not yet open
Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)
NCT06621095Pancreatic Cancer, First-line, Metastatic Pancreatic Cancer
RenJi Hospital
Phase 2
104
Shanghai
2024-10-30
Active, closed
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
NCT06762158Esophageal Squamous Cell Carcinoma (ESCC)
RenJi Hospital
Not applicable
50
Shanghai
2024-10-30
Active, closed
Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
NCT06497062Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase 2
47
Shanghai
2024-10-30
Not yet open
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
NCT06656234Diffuse Large B Cell Lymphoma (DLBCL)
Ruijin Hospital
Observational
200
Shanghai
2024-10-30
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
Janssen Research & Development, LLC
Phase 3
196
Beijing, Changzhou, Hangzhou, Shanghai, Shenyang
2024-10-29
Recruiting
An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors
NCT06238401Advanced Solid Tumors
Hangzhou Adcoris Biopharmacy Co., Ltd
Phase 1
77
Beijing, Zhejiang, Shandong, Shanghai
2024-10-29
Active, closed
Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects
NCT07134478Healthy Subjects
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
24
Shanghai
2024-10-28
Active, closed
An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease
NCT06663878Wilson Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
9
Shanghai
2024-10-28
Recruiting
Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control
NCT06591286Diabetes Mellitus, Type 2
Shanghai 6th People's Hospital
Not applicable
150
Shanghai
2024-10-25
Recruiting
A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
NCT06709690Paediatric Patients
Ruijin Hospital
Observational
35
Shanghai
2024-10-25
Recruiting
Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
NCT06637163Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
100
Shantou, Shenyang, Shanghai, Tianjin, Hangzhou
2024-10-24
Recruiting
Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer
NCT06591650Gallbladder Cancer Unresectable
Fudan University
Phase 2
33
Shanghai
2024-10-24
Recruiting
Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy
NCT06900049Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
12
Shanghai
2024-10-24
Active, closed
A Study of Single Dose of LP-003 in Healthy Adult Subjects
NCT06604949Chronic Spontaneous Urticaria
Longbio Pharma
Phase 1
12
Shanghai
2024-10-23
Recruiting
OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
NCT06781944Primary Membranous Nephropathy
Huashan Hospital
Phase 3
144
Shanghai
2024-10-23
By invitation
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma
NCT06637254Bronchial Asthma
Haisco Pharmaceutical Group Co., Ltd.
Phase 2
219
Shanghai
2024-10-22
Recruiting
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
NCT06649331Advanced Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer (TNBC), HER2-negative Breast Cancer
Fudan University
Phase 2
160
Shanghai
2024-10-21
Recruiting
AI-Driven CTA Reconstruction for Intracranial LVO
NCT06645405Acute Ischemic Stroke, Artificial Intelligence (AI), Endovascular Thrombectomy, CT Angiography
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Not applicable
174
Shanghai
2024-10-20
Recruiting
AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial
NCT06642948Musculoskeletal Symptoms, Breast Cancer, Endocrine Therapy, Aromatase Inhibitors
Fudan University
Not applicable
80
Shanghai
2024-10-20
Active, closed
AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer
NCT06591520Biliary Tract Cancer
Akeso
Phase 3
682
Harbin, Shanghai
2024-10-20
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
NCT06644274Gastrointestinal Malignancies
Ruijin Hospital
Observational
40
Shanghai
2024-10-20
Recruiting
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
NCT06458257Acute Myeloid Leukemia
Ruijin Hospital
Observational
50
Shanghai
2024-10-19
Recruiting
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
NCT06090994Colorectal Cancer
Fudan University
Phase 4
756
Harbin, Changzhou, Nanjing, Yangzhou, Shanghai, Hangzhou, Ningbo
2024-10-18
Recruiting
The Impact of Soft Contact Lenses on the Corneal Neuromediators and Optical Quality in High Myopia Prior to SMILE
NCT06650306Contact Lens Complication
yuhao shao
Observational
80
Shanghai
2024-10-18
Active, closed
Phase 3 Study of Vorasidenib (S095032/AG-881) in Asian Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 orIDH2 Mutation
NCT06780930Residual or Recurrent Grade 2 IDH Mutant Glioma
Servier
Phase 3
57
Shenzhen, Chengdu, Beijing, Shanghai, Xi'an
2024-10-18
Active, closed
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
NCT06640049Neoplasms, Rectal
GlaxoSmithKline
Phase 2
23
Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Kunming, Shanghai
2024-10-17
Recruiting
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
NCT06515314Hepatic Cell Carcinoma
Shanghai Ruiliyuan Biotechnology Co., Ltd.
Phase 1
12
Shanghai
2024-10-17
Active, closed
Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.
NCT07274761Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
24
Shanghai
2024-10-17
Recruiting
A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors
NCT06612840Non-small Cell Lung Cancer, Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
20
Shanghai
2024-10-16
Recruiting
Acute Effects of Cold Exposure on Cardiovascular System
NCT06652425Cardiovascular System
Fudan University
Not applicable
40
Shanghai
2024-10-16
Active, closed
Acute Effects of Low Temperature Exposure on Respiratory System
NCT06652932Lung Function
Fudan University
Not applicable
40
Shanghai
2024-10-16
Active, closed
Acute Effects of Cold Exposure on Cognitive Function
NCT06654167Cognitive Function
Fudan University
Not applicable
40
Shanghai
2024-10-16
Recruiting
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
NCT06539624Fabry Disease
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
12
Shanghai, Hangzhou
2024-10-16
Recruiting
DEB-TACE Prior to Liver Transplantation in the Treatment of HCC
NCT06353126Liver Cancer
RenJi Hospital
Phase 4
40
Shanghai
2024-10-16
Recruiting
Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
NCT06589089Diffuse Large B Cell Lymphoma
Ruijin Hospital
Phase 2
18
Shanghai
2024-10-15
Recruiting
Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
NCT06241482Neurocritical Care, Traumatic Brain Injury, Cerebrovascular Disease, Moderate or Severe Coma
Shanghai 6th People's Hospital
Not applicable
80
Shanghai
2024-10-15
Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
NCT06644287Advanced Soft Tissue Sarcomas
Ruijin Hospital
Observational
40
Shanghai
2024-10-15
Recruiting
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
NCT07031661High-risk, Bipolar Disorder, Atypical Depression
Shanghai Mental Health Center
Observational
1,200
Shanghai
2024-10-15
Not yet open
Efficacy and Safety Research of Cold Snare Polypectomy and Hot Snare Polypectomy in the Treatment of 4-9 mm Diameter Colorectal 0-Isp and 0-Ip Polyps: a Prospective, Multicenter, Randomized Controlled Study(FAST -REST Study)
NCT06658561Cold Snare Resection, Hot Snare Resection, Polyps of Colon
Ruijin Hospital
Not applicable
982
Shanghai
2024-10-15
Recruiting
Clinical Study on the Safety and Efficacy of Human Amniotic Mesenchymal Stem Cells in the Treatment of Premature Ovarian Insufficiency
NCT07115082Premature Ovarian Insufficiency
Yan Hongli
Phase 1/2
50
Shanghai
2024-10-15
Not yet open
LED Therapy for Third Molar Surgery
NCT06640439Molar, Third, Photobiomodulation, Photobiomodulation Therapy, Third Molar Surgery
Huashan Hospital
Phase EARLY_PHASE1
50
Shanghai
2024-10-14
Recruiting
Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer
NCT06547736Pancreatic Cancer
Fudan University
Phase 2
160
Shanghai
2024-10-14
Recruiting
A Phase Ib Study of GC101 in NSCLC
NCT06473961Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer
Shanghai Juncell Therapeutics
Phase 1
20
Shanghai
2024-10-14
Recruiting
Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
NCT06698965Lung Cancer, Small Cell
Shanghai Chest Hospital
Phase 2
52
Shanghai
2024-10-13
Recruiting
Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis
NCT07153809Acute Pancreatitis, Severe Acute Pancreatitis
Changhai Hospital
Not applicable
80
Shanghai
2024-10-12
Recruiting
Profile and Regulatory Network of Exercise in Improving Metabolic Phenotypes of Patients With Prediabetes
NCT06633575Prediabetes
Shanghai Zhongshan Hospital
Not applicable
40
Shanghai
2024-10-12
Recruiting
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
NCT06418659Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
37
Shanghai
2024-10-12
Recruiting
MRI Performance and Risk Factors in Bilateral Vestibular Hypofunction
NCT07709143Bilateral Vestibular Hypofunction, Bilateral Vestibulopathy, Presbyvestibulopathy
Shanghai 6th People's Hospital
Observational
120
Shanghai
2024-10-11
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
NCT06581432Solid Tumours
Boehringer Ingelheim
Phase 2
588
Beijing, Changsha, Hangzhou, Hefei, Nanchang, Nanjing, Shanghai, Wuhan
2024-10-11
Recruiting
Investigation of Cardiac Function Following Low-Intensity Ultrasound Intervention
NCT06567106Cardiac Function
ShanghaiTech University
Not applicable
6
Shanghai
2024-10-10
Recruiting
Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy
NCT07135661Breast Cancer, Proton Therapy
Shanghai Proton and Heavy Ion Center
Not applicable
312
Shanghai
2024-10-10
Recruiting
Study of LM-299 in Subjects Advanced Malignant Tumors
NCT06650566Malignant Tumors
LaNova Medicines Limited
Phase 1/2
108
Xinxiang, Liaocheng, Zibo, Shanghai
2024-10-09
Not yet open
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
NCT06594211Multiple Myeloma
RenJi Hospital
Not applicable
18
Shanghai
2024-10-09
Recruiting
QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
NCT06786026TNBC, Triple Negative Breast Cancer
Fudan University
Phase 2
60
Shanghai
2024-10-09
Recruiting
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
NCT06590220Thyroid Associated Ophthalmopathy
Shanghai Changzheng Hospital
Observational
150
Shanghai
2024-10-09
Active, closed
LuX-Valve Plus System for Severe or Greater Tricuspid Regurgitation
NCT07705594Tricuspid Regurgitation (TR)
Jenscare Scientific
Not applicable
126
Shanghai
2024-10-09
Recruiting
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
NCT06682195TNBC, Triple Negative Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
35
Nanchang, Hangzhou, Harbin, Hefei, Jinhua, Nantong, Shanghai, Shanxi
2024-10-09
Not yet open
The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer
NCT06635096Breast Cancer Female
Fudan University
Not applicable
60
Shanghai
2024-10-08
Active, closed
Endocrine and Exocrine Secretory Function Alterations After Moderately Severe and Severe Acute Pancreatitis
NCT06590935Acute Pancreatitis (AP), Diabetes Mellitus
Shanghai Changzheng Hospital
Observational
120
Shanghai
2024-10-08
Recruiting
Efficacy and Safety of tACS for Depression: a Multicenter RCT Study
NCT06891326Depression Disorders
Ruijin Hospital
Not applicable
72
Shanghai
2024-10-08
Recruiting
AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NCT06632886Lung Cancers, Liver Cancer, Gastric Cancers, Colorectal, Cancer
Guo ShiWei
Not applicable
1,000,000
Shanghai
2024-10-07
Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
NCT06598306Extensive Stage Small Cell Lung Cancer
Amgen
Phase 1
220
Changchun, Shanghai
2024-10-07
Recruiting
A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
NCT06605222Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1/2
201
Shanghai
2024-10-04
Recruiting
6-year Follow-up Data After the Berberine Intervention Trial
NCT06629051Colorectal Adenoma, Colorectal Cancer Control and Prevention, Colorectal Polyps
Shanghai Jiao Tong University School of Medicine
Observational
891
Shanghai
2024-10-04
Recruiting
Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
NCT07492693Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
Changhai Hospital
Phase 2
40
Shanghai
2024-10-01
Recruiting
Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm
NCT04850456Critical Illness, Sepsis, Severe
Children's Hospital of Fudan University
Observational
200
Shanghai
2024-10-01
Recruiting
High-dose Furmonertinib or Combined With Chemotherapy in EGFR-mutant Advanced NSCLC After Disease Progression on Third-generation EGFR-TKI
NCT06652048Non-Small Cell Lung Cancer
Jialei Wang
Phase 2
60
Shanghai
2024-10-01
By invitation
Retrospective Study on Leptomeningeal Metastasis of Solid Tumors
NCT06705049Leptomeningeal Metastasis
Shanghai Zhongshan Hospital
Observational
107
Shanghai
2024-10-01
Active, closed
Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer
NCT06583655Breast Cancer Invasive
Ruijin Hospital
Not applicable
205
Shanghai
2024-10-01
Active, closed
Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease
NCT06920212Fecal Microbiota Transplantation
Shanghai 10th People's Hospital
Not applicable
30
Shanghai
2024-10-01
Not yet open
EMR Versus CSP in the Treatment of Sessile Serrated Lesions Less Than 10mm in Size
NCT06609031Colorectal Sessile Serrated Lesion
Fudan University
Not applicable
270
Shanghai
2024-10-01
Rows per page Showing 2101–2200 of 3827
Previous 20 21 22 23 24 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=22

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.